# Yikon Genomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yikon-genomics

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.yikongenomics.com
- Total disclosed funding: $93M
- Latest round: Series D (May 6, 2021)
- Investors on record: 11

## About

Established in 2012 and based in Shanghai, China, Yikon Genomics operates as a gene testing platform that provides gene testing and therapy for fertility and tumor. The company's subsidiaries include Shanghai Xukang Medical Technology Co., Ltd., Shanghai Yikang Medical Laboratory Co., Ltd., Suzhou Yikang Medical Laboratory Co., Ltd. and Xukang Medical Technology (Suzhou) Co., Ltd., and have offices in Guangzhou and Wuhan. In October 2020, Yikon Genomics raised an undisclosed amount of unspecified funding from new investors Century Golden Resources Group, CICC Capital Management and Shanghai Guofang Fund Management.

The company engages in the sales and production of gene testing and therapy for fertility and tumor. The company is committed to the development and application of single-cell whole-genome and transcriptome amplification sequencing technologies to provide precision medical testing services for reproductive health and tumor prevention and treatment.

In the future, the company will promote product technology research and development, clinical trials, channel expansion, market promotion and clinical transformation in the full cycle of reproductive health and tumor screening and diagnosis and treatment.

## Funding rounds

- Series D, May 6, 2021, $39M — YF Capital, Shanghai Jianyi Private Equity Fund Management, Shanghai CCI Investment, General Technology Venture Capital Co., Ltd., Oriza Holdings
- Series C, Nov 4, 2019, $31M — BOCOM International Asset Management, Yuexiu Industrial Investment Funds Management, Jinyuan Kuntong Equity Investment Management, Zhongyuan Jiupai Industry Investment Management
- Series B, Oct 1, 2016, $22M — Yuexiu Industrial Investment Funds Management, 6 Dimensions Capital, Shenzhen New Industry Venture Capital

## Investors

- Yuexiu Industrial Investment Funds Management (https://capitalatlas.ai/funds/yuexiu-industrial-investment-funds-management) — Series B, Series C
- 6 Dimensions Capital (https://capitalatlas.ai/funds/6-dimensions-capital) — Series B
- Shenzhen New Industry Venture Capital — Series B
- BOCOM International Asset Management (https://capitalatlas.ai/funds/bocom-international-asset-management) — Series C
- Jinyuan Kuntong Equity Investment Management (https://capitalatlas.ai/funds/jinyuan-kuntong-equity-investment-management) — Series C
- Zhongyuan Jiupai Industry Investment Management (https://capitalatlas.ai/funds/zhongyuan-jiupai-industry-investment-management) — Series C
- YF Capital (https://capitalatlas.ai/funds/yf-capital) — Series D
- Shanghai Jianyi Private Equity Fund Management (https://capitalatlas.ai/funds/shanghai-jianyi-private-equity-fund-management) — Series D
- Shanghai CCI Investment — Series D
- General Technology Venture Capital Co., Ltd. — Series D
- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Series D